sanofi-aventis

1 Onslow Street, Guildford, Surrey, GU1 4YS, UK
Telephone: +44 (0)1483 505 515
Fax: +44 (0)1483 535 432
Medical Information e-mail: uk-medicalinformation@sanofi-aventis.com

Patient Information Leaflet last updated on the eMC: 22/07/2011
PIL Cordarone X Intravenous

When a pharmaceutical company changes an SPC or PIL, a new version is published on the eMC. For each version, we show the dates it was published on the eMC and the reasons for change.

Updated on 22/07/2011 and displayed until Current
Reasons for adding or updating:
  • Change of trade or generic name
Updated on 18/04/2011 and displayed until 22/07/2011
Reasons for adding or updating:
  • Change to warnings or special precautions for use
  • Change to dosage and administration
Updated on 08/03/2011 and displayed until 18/04/2011
Reasons for adding or updating:
  • Change due to harmonisation of PIL.
  • Change to side-effects
Updated on 28/04/2009 and displayed until 08/03/2011
Reasons for adding or updating:
  • Change to side-effects
  • Change to drug interactions
Updated on 06/11/2008 and displayed until 28/04/2009
Reasons for adding or updating:
  • Change due to user-testing of patient information
  • Change due to user-testing of patient information
Updated on 08/08/2007 and displayed until 06/11/2008
Reasons for adding or updating:
  • Change to warnings or special precautions for use
Updated on 03/05/2006 and displayed until 08/08/2007
Reasons for adding or updating:
  • Change to drug interactions
Updated on 30/09/2004 and displayed until 03/05/2006
Reasons for adding or updating:
  • New PIL for eMC ie a PIL for an existing product but one that is new to the eMC

Active Ingredients/Generics

 
   amiodarone hydrochloride